3Martin GS, Mannino DM, Eaton S,et al. The epidemiology of sepsis in the United States from 1979 through 2000 [J]. N Engl J Med,2003,348:1546.
4Mukhopadhyay C, Bhargava A, Ayyagari A. Role of mechanical ventilation & development of multidrug resistant organisms in hospital acquired pneumonia [J]. Indian J Med Res,2003,118:229.
5Pfaller MA, Pappas PG, Wingard JR. Invasive fungal pathogens : current epidemiological trends [J]. Clin Infect Dis,2006,43 (Suppl 1):S3.
6DiNubile MJ, Strohmaier KM, Lupinaeci RJ, et al. Efficacy and safety of easpofungin therapy in elderly patients with proven or suspected invasive fungal infeetions[J]. Eur J Clin Microbiol Infect Dis, 2008,27: 663.
7Colombo AL, Perfect J, DiNubile M, et al. Global distribution and outcomes for candida species causing invasive candidiasis: results from an International Randomized Double-Blind Study of Caspofungin Versus Amphotericin B for the Treatment of Invasive Candidiasis[J]. Eur J Clin Microbiol Infect Dis, 2003,22 : 470.
8Lai CC,Tan CK, Huang YT, et al. Current challenges in the management of invasive fungal infections[J]. J Infect Chemother, 2008,14 : 77.
